Typhoid Vaccine Wyeth - Biotech, Pharma and Life Science Channel

23:11 EST 27th November 2014 | BioPortfolio

PubMed Articles [1529 Associated PubMed Articles listed on BioPortfolio]

Proteomics Characterization of Tick-Host-Pathogen Interactions.

Ticks are blood-feeding arthropod ectoparasites of wild and domestic animals that transmit disease-causing pathogens to humans and animals worldwide and a good model for the characterization of tick-h...

Why are anogenital warts diagnoses decreasing in the UK: bivalent human papillomavirus (HPV) vaccine cross-protection or failure to examine?

Potential effect of virus interference on influenza vaccine effectiveness estimates in test-negative designs.

SUMMARY A hypothetical influenza infection-induced non-specific immunity may reduce the risk of subsequent non-influenza respiratory virus (NIRV) infection and bias the influenza vaccine effectiveness...

Secular trends in invasive meningococcal disease, Massachusetts, 1988-2011: what happened to invasive disease?

SUMMARY Invasive meningococcal disease (IMD) reported to the Massachusetts Department of Public Health from 1988 to 2011 was reviewed. The average annual incidence of IMD/100 000 decreased from 1·57...

Immunogenicity and safety of inactivated quadrivalent and trivalent influenza vaccines in children 18-47 months of age.

Because inactivated trivalent influenza vaccines (TIVs) contain 1 influenza B strain, whereas 2 lineages may co-circulate, B lineage mismatch is frequent. We assessed an inactivated quadrivalent influ...

Safety and Comparability of Controlled Human Plasmodium falciparum Infection by Mosquito Bite in Malaria-Naïve Subjects at a New Facility for Sporozoite Challenge.

Controlled human malaria infection (CHMI) studies which recapitulate mosquito-borne infection are a critical tool to identify protective vaccine and drug candidates for advancement to field trials. In...

Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice.

Hematopoietic stem cell transplant (HCT) recipients are more susceptible to infections from vaccine-preventable diseases than the general population. Despite the development of international consensus...

Pathotypic and Sequence Characterization of Newcastle Disease Viruses from Vaccinated Chickens Reveals Circulation of Genotype II, IV and XIII and in India.

Newcastle disease virus (NDV) causes a highly contagious disease which continuously haunts the global poultry industry. The nature and molecular epidemiology of NDVs prevalent in recent outbreaks in I...

Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen.

The development of an effective vaccine is critical for prevention of a Middle East respiratory syndrome coronavirus (MERS-CoV) pandemic. Some studies have indicated the receptor-binding domain (RBD) ...

The safety of seasonal influenza vaccines in Australian children in 2013.

Objective: To examine influenza vaccine safety in Australian children aged under 10 years in 2013. Design, participants and setting: Active prospective surveillance study conducted with parents or car...

News Articles [2662 Associated News Articles listed on BioPortfolio]

Italy's pharmaceutical watchdog raises alarm on batches of flu drug

ROME (Reuters) - Italy's pharmaceutical watchdog AIFA suspended two batches of anti-flu vaccine FLUAD made by Switzerland's Novartis on Thursday, saying three deaths potentially connected to the drug ...

NewLink Genetics Scores Partnership With Merck For Experimental Ebola Vaccine

On Monday November 24th 2014 NewLink Genetics (NLNK) had announced that it had entered into a partnership agreement with Merck (MRK) to co-develop an experimental vaccine for Ebola known as rVSV-EBOV....

Italy bans Novartis flu vaccine after suspicious deaths

Italy suspended the use of a flu vaccine made by Swiss pharmaceuticals giant Novartis on Thursday amid fears it may have caused three deaths.

Flu shot two years in a row may lower effectiveness

A new study from the University of Michigan has yielded more evidence that getting a flu shot 2 years in a row may result in lower vaccine effectiveness (VE) in […]

Ebola vaccine shows promise in human trials

“Ebola vaccine trial results promising, says manufacturer,” The Guardian reports. Initial results from a trial involving 20 healthy adults found that the vaccine seems to be safe.The trial was wha...

Happy Thanksgiving for GSK with FTC approval of Novartis vaccine biz

Just in time for the holidays, GSK can ‘give thanks’ to the US Federal Trade Commission (FTC) which has approved the $7bn acquisition of Novartis’ vaccine business.

Positive early results for GSK/NIAID Ebola vaccine

A phase I trial on an experimental vaccine to prevent Ebola virus disease show it was well-tolerated and produced immune system responses in all 20 healthy adults who received it.Co-developed by Glaxo...

Early results from GSK and NIH's Phase I Ebola vaccine show promise

UK pharma major GlaxoSmithKline has reported promising preliminary results from a small Phase I trial of its Ebola vaccine, being developed in collaboration with the National Institutes of Health.

Freshers told ‘it’s not too late’ for MenC vaccine

Recent reports of meningitis and septicaemia cases in students... The post Freshers told ‘it’s not too late’ for MenC vaccine appeared first on European Pharmaceutical Review.

GSK Ebola vaccine ‘promising’ in early trials

The first trial results for GlaxoSmithKline’s (GSK) Ebola vaccine candidate have shown that the medicine was well-tolerated and produced an immunological response in the participants. The small Phas...

Events [0 Results]

None

Companies [89 Associated Companies listed on BioPortfolio]

Genocea Biosciences

Genocea Biosciences was founded in 2006 to commercialize key breakthroughs in vaccine discovery and development. The Company’s proprietary T cell-directed antigen disc...

The Vaccine & Gene Therapy Institute of Florida

ImmusanT Inc.

ImmusanT is a privately-held biotechnology company focused on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that aim to improve diagn...

Affinivax Inc.

Affinivax is advancing a next generation conjugate vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challengi...

Mucosis B.V.

Mucosis B.V. (Mucosis) is a clinical-stage biotechnology company using a proprietary technology platform to develop next-generation needle-free human vaccines for infectious disea...

Vaxart, Inc.

Vaxart is a privately owned company developing oral recombinant vaccines based on its proprietary delivery platform. The Vaxart platform is suitable to deliver any protein vaccine...

Mucosis

Mucosis B.V. is a clinical-stage biotechnology company developing novel vaccines on its proprietary Mimopath® platform technology. The Mimopath® platform is being studied fo...

Shoo the Flu

The flu, also called influenza, is a contagious disease that spreads by coughing, sneezing and close contact. Flu symptoms include fever/chills, sore throat, muscle aches, fatigue...

Redbiotec

Redbiotec is a privately held Swiss biopharmaceutical company founded in 2006 and based in Zurich-Schlieren. The company uses its proprietary rePAX® co-expression tec...

Biosceptre

Biosceptre has identified a pan-cancer target, present in many cancer types, and importantly not found in healthy tissue. Early research and initial evidence suggest that drugs di...

Clinical Trials [2100 Associated Clinical Trials listed on BioPortfolio]

Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine

The purpose of this trial is to describe the safety and antibody response to revaccination with Menactra vaccine in persons who received their first dose at ≥11 years of age. Primary Ob...

Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women

Human papillomavirus (HPV) is the most common sexually transmitted disease in the world. HPV infection can cause genital warts and certain cervical problems, including cervical cancer. HPV...

Immune Responses to Smallpox Vaccination

This study will examine how people s immune systems respond to inoculation with vaccinia virus the standard vaccine used to protect against smallpox and how these responses correlat...

A Study to Assess a New Ebola Vaccine, cAd3-EBO Z

The purpose of this study is to assess a new Ebola vaccine, cAd3-EBO Z, at different doses. The study will enable us to assess the safety of the vaccine and the extent of the immune respon...

A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines

The aim of the study is to generate safety and immunogenicity data with Oral Cholera Vaccine (Shanchol™) in The Philippines Objectives: - To describe the safety after each dos...

CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301in Treating Patients With Stage IIB-IV Melanoma

This randomized phase II trial studies how well DEC-205/NY-ESO-1 fusion protein CDX-1401 (CDX-1401) and neoantigen-based melanoma-poly-ICLC vaccine (poly-ICLC) vaccine therapy work when gi...

Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls

This study has been designed to evaluate the immunogenicity and safety of GSK Biologicals' HPV-16/18 vaccine when administered according to alternative 2-dose schedules (0,6 months and 0,1...

Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population

The purpose of this study is to determine whether the cancer vaccine Tecemotide (L-BLP25) in addition to best supportive care is effective in prolonging the lives of Asian patients with un...

Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer

NSCLC tumors are appropriate targets for active immunotherapy, because they are non-immunogenic, which indicates that NSCLC does not stimulate a spontaneous immune response. NSCLC t...

Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine in Healthy Female Children

The current study will evaluate the immunogenicity and safety of Cervarix when administered according to a 2-dose schedule with or without co-administration of GSK Biologicals' MMR and DTP...

Videos

What makes a conjugated vaccine different from a non-conjugated

What makes a conjugated vaccine by Kevin M. windisch MD FAAP and Sparks Pediatric and adolescent medicine.

Medical and Biotech [MESH] Definitions

A combined vaccine used to prevent infection with diphtheria and tetanus toxoid. This is used in place of DTP vaccine (DIPHTHERIA-TETANUS-PERTUSSIS VACCINE) when PERTUSSIS VACCINE is contraindicated.

A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)

A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.

Vaccines used to prevent TYPHOID FEVER and/or PARATYPHOID FEVER which are caused by various species of SALMONELLA. Attenuated, subunit, and inactivated forms of the vaccines exist.

Search BioPortfolio:
Loading
Advertisement
Advertisement
review and buy Typhoid Vaccine Wyeth market research data and corporate reports here

Channels Quicklinks